0001209191-23-043195.txt : 20230724 0001209191-23-043195.hdr.sgml : 20230724 20230724162053 ACCESSION NUMBER: 0001209191-23-043195 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230720 FILED AS OF DATE: 20230724 DATE AS OF CHANGE: 20230724 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kirk Christopher J. CENTRAL INDEX KEY: 0001744253 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38542 FILM NUMBER: 231105255 MAIL ADDRESS: STREET 1: C/O KEZAR LIFE SCIENCES, INC. STREET 2: 4000 SHORELINE COURT, SUITE 300 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Kezar Life Sciences, Inc. CENTRAL INDEX KEY: 0001645666 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 473366145 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4000 SHORELINE COURT, SUITE 300 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-822-5600 MAIL ADDRESS: STREET 1: 4000 SHORELINE COURT, SUITE 300 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 doc4.xml FORM 4 SUBMISSION X0508 4 2023-07-20 0 0001645666 Kezar Life Sciences, Inc. KZR 0001744253 Kirk Christopher J. C/O KEZAR LIFE SCIENCES, INC. 4000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080 1 0 0 0 0 Common Stock 2023-07-20 4 M 0 48950 0.90 A 431348 D Employee Stock Option (right to buy) 0.90 2023-07-20 4 M 0 48950 0.00 D 2025-09-09 Common Stock 48950 74411 D Total reflects 914 shares of common stock acquired on November 15, 2022 through the Company's 2018 Employee Stock Purchase Plan. Fully vested and exercisable. /s/ Marc Belsky, Attorney-in-fact 2023-07-24